The health care reform will greatly affect the medical technology industry in both positive and negative ways. Although the healthcare reform supports greater emphasis being placed on prevention and preserving wellness, which broaden the field for the development of medical technology industry, it also could have negative effects on research, profits, and investments as the medical device excise tax is authorized. The demand for products can be rises as coverage is expanded, but the demand also be reduce due to the price pressure put on the manufacture companies. Since the government has the healthcare field price-controlled, the innovations and access are possibly limited as the result.
Some positive effects of the reform on the healthcare industry can be listed. First of all, under the ACA, there is healthcare coverage expansion, which leads to the increase in demand for products and thus also to the increase of market for medical devices and diagnostics. This expansion will definitely push up national health spending on healthcare (about 1.7 percent between 2014 and 2019), which may be thought as the accretion in investment of medical technology industry. However, this increase is not much considered in term of older population versus overall healthcare spending.
In additional, the change in payment rule in healthcare reform put many strict provisions on hospital’s conditions. Since the conditions acquired during healthcare and hospital-acquired conditions (the downgrade of patients’ health during hospital residence because of nosocomial conditions) are taken into account to determine the quality and efficiency of the hospitals, the hospitals have to pay more attention to their in-hospital conditions in order to obtain their payment associated with Medicare programs. This somehow gives the opportunities for the device market that help in preventing the unfavorable events. For example, ventilators and catheters are equipped to prevent infections, and there is also “spur sales of diagnostic tests that provide rapid identification of contagious infections like methicillin-resistant staphylococcus (MRSA), which can spread quickly in hospitals.”  As the ACA also put wellness and preventive services on checking to improving population health, these features offer “clear market opportunities for in vitro diagnostic tests and imaging studies used for screening.” 
Moreover, one of the most important themes of healthcare reform is the comparative effectiveness research (CER). CER has been suggested as a part of the strategy in healthcare reform for improving outcomes and helping to reduce the growth in costs. The clinical therapies, diagnosis tests, observational studies all need the assistance of medical technology to providing superior clinical solutions, thus it is really matter if the medical materials they obtain are comparatively effective. As the CER suggests “new product will not be accepted in the medical market place unless it is also...